Pyridine → HCID 59437496, compound
Reaction equation
N1C=CC=CC=1.[CH:7]1([NH:13][C:14]2[N:19]3[N:20]=[C:21]([NH2:23])[N:22]=[C:18]3[CH:17]=[CH:16][CH:15]=2)[CH2:12][CH2:11][CH2:10][CH2:9][CH2:8]1.Cl.Cl[CH2:26][C:27]1[N:32]=[CH:31][C:30]([C:33](Cl)=[O:34])=[CH:29][CH:28]=1.[NH:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1>C(Cl)Cl.C1COCC1>[CH:7]1([NH:13][C:14]2[N:19]3[N:20]=[C:21]([NH:23][C:33](=[O:34])[C:30]4[CH:29]=[CH:28][C:27]([CH2:26][N:36]5[CH2:41][CH2:40][O:39][CH2:38][CH2:37]5)=[N:32][CH:31]=4)[N:22]=[C:18]3[CH:17]=[CH:16][CH:15]=2)[CH2:8][CH2:9][CH2:10][CH2:11][CH2:12]1Participants
Conditions
- Temperature
- 60 °C
Procedure
Pyridine (198 mg; 2.5 mmol; 5.0 eq.) was added to a solution of N5-cyclohexyl[1,2,4]triazolo[1,5-a]pyridine-2,5-diamine ((A9), 116 mg; 0.50 mmol; 1.0 eq.) in DCM (2.0 mL). 6-(chloromethyl)pyridine-3-carbonyl chloride hydrochloride (190 mg; 1.0 mmol; 2.0 eq.) was added and the resulting black solution was stirred under reflux for 14 h. The solvents were evaporated to yield a black oil. Morpholine (218 mg; 2.5 mmol; 5.0 eq.) and THF (0.5 mL) were added to this residue, and the mixture was then stirred and heated at 60° C. for 12 h. Purification by RP-HPLC (Waters Sunfire™ Prep C18 OBD™ 5 μM, 100×49 mm) following a gradient starting with 20/80 (0.1% formic acid in CH3CN/0.1% formic acid in H2O) up to 95/5 in 12 min. The fractions were collected and lyophilized to give the title compound as a white powder (20 mg, 9%). HPLC, Rt: 2.11 min. (purity 100%). LC/MS, M+(ESI): 436.3.
Workup
- temperatureunder reflux for 14 h
- customThe solvents were evaporated
- customto yield a black oil
- stirringthe mixture was then stirred
- customPurification by RP-HPLC (Waters Sunfire™ Prep C18 OBD™ 5 μM, 100×49 mm)
- customThe fractions were collected
Sources & evidence
- ORD record
- ord-17c9a930b34843bdac828600c9566a35
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08263595B2
Reaction notes
Loading…